Early Identification of SARS-CoV-2 Emergence in the DoD via Retrospective Analysis of 2019-2020 Upper Respiratory Illness Samples
Chapleau, R. R.; Christian, M.; Connors, B.; Premo, C.; Chao, T.; Rodriguez, J.; Huntsberger, S.; Meyer, J.; Javorina, A.; Reynolds, K.; Riddle, D. S.; Lisanby, M. W.; Starr, C. R.
Show abstract
The first case of non-travel related SARS-COV-2 was detected late February 2020 in California, however the delay of diagnostic testing and initial stringent testing criteria made it difficult to identify those who could have acquired it through community spread. There was speculation by many that the virus may have been circulating at least a month earlier [1], and environmental sampling has suggested that versions of this virus were found many months before the first human samples were identified [2]. Here we performed a retrospective study from residual samples collected from a global DoD Respiratory Surveillance Program to establish a tentative timeline by which this virus was circulating in our DoD population. We performed RT-PCR for SARS-COV-2 and compared to the dates of these cases to the first cases identified in respective states and counties using the Johns Hopkins COVID tracker website. Twenty-four positive samples were identified out of approximately 7,000 tested. Although we found some early cases in certain regions, we did not see circulation before late February in samples collected both in the US and outside the USA. SUMMARYO_ST_ABSWhat is already known about this topic?C_ST_ABSWe know that the first reported case of SARS-COV-2 was mid-January; however, there has been conjecture that the virus was found in the community before this date. What is added by this report?Here we took samples collection from a global respiratory surveillance program and evaluated for the presence of SARS-COV-2 RNA. The first case we found in the surveillance program was approximately 30-60 days before the first case was identified on military installations via diagnostic testing, however was not earlier than the mid-January reported case in California. What are the implications for public health practice?The implementation of new and emerging pathogen detection assays into already established surveillance programs could detect early community spread and possibly reduce spread of pathogen among vulnerable populations.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Presence and Stability of SARS-CoV-2 on Environmental Currency and Money Cards 94%
- An international, interlaboratory ring trial confirms the feasibility of an open-source, extraction-less “direct” RT-qPCR method for reliable detection of SARS-CoV-2 RNA in clinical samples 94%
- Performance of the TaqMan™ COVID-19 Pooling Kit for detection of SARS-CoV-2 in Asymptomatic and Symptomatic populations at an Institution of Higher Education 94%
Similar papers in this journal
- Estimating the false positive rate of highly automated SARS-CoV-2 nucleic acid amplification testing 94%
- Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution 94%
- Assessment of sample pooling for clinical SARS-CoV-2 testing 94%
Similar papers in this journal
- Evaluation of the INDICAID™ COVID-19 Rapid Antigen Test in symptomatic populations and asymptomatic community testing 95%
- Clinical evaluation of BD Veritor™ SARS-CoV-2 and Flu A+B Assay for point-of-care (POC) System 94%
- Performance of the Cue COVID-19 Molecular Test for Point of Care: Insights from a multi-site clinic service model 93%
Similar papers in this journal
- Aerosolized Hydrogen Peroxide Decontamination of N95 Respirators, with Fit-Testing and Virologic Confirmation of Suitability for Re-Use During the COVID-19 Pandemic 91%
- Liquid chalk is an antiseptic against SARS-CoV-2 and influenza A respiratory viruses 91%
- The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization 91%
Similar papers in this journal
- Performance of Repeat BinaxNOW SARS-CoV-2 Antigen Testing in a Community Setting, Wisconsin, November-December 2020 94%
- The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs 93%
- Impact of SARS-CoV-2 on Seasonal Respiratory Viruses: A Tale of Two Large Metropolitan Centers in the United States 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.